Seeking Alpha

Covidien (COV +1.2%) continues the rise it began on Tuesday last week ahead of its FQ3 EPS beat...

Covidien (COV +1.2%) continues the rise it began on Tuesday last week ahead of its FQ3 EPS beat on Thursday and hits a new 52-week high of $56.21. SA author Stephen Simpson calls Covidien "a leading growth story at a reasonable price." The company today said it has received 510(K) clearance for its Nellcor Bedside SpO2 Patient Monitoring System.
Comments (1)
  • rhiannion
    , contributor
    Comments (232) | Send Message
     
    And this has to with Kellogg (K) how?
    30 Jul 2012, 12:45 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|